You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenocarcinoma of unknown primary

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Positron Emission Tomography in Detecting Primary Tumor in Cases

Recruiting
  • Metastasis of Unknown Origin
  • PET/CT
  • Sohag, Egypt
    Sohag university Hospital
Oct 11, 2023

Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior

Recruiting
  • Solid Tumor
  • +15 more
  • RAPA-201 Rapamycin Resistant T Cells
  • Chemotherapy Prior to RAPA-201 Therapy
  • Hackensack, New Jersey
    Hackensack University Medical Center
Dec 23, 2021

Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)

Recruiting
  • Unknown Primary Tumors
  • Oropharynx Cancer
  • Detection of lesions using fluorescence molecular imaging
  • Groningen, Netherlands
    University Medical Center Groningen
Oct 20, 2023

Unknown Primary Carcinoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Terminated
Has Results
  • Unknown Primary Carcinoma
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Dec 14, 2020

Cancer of Unknown Primary Site, Unknown Primary Cancer, Unknown Primary, Squamous Cell Carcinoma Trial in Copenhagen, Århus

Recruiting
  • Cancer of Unknown Primary Site
  • +2 more
  • Transoral Ultrasound
  • Copenhagen, Denmark
  • +1 more
May 2, 2023

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Recruiting
  • Unknown Primary Tumors
  • DNA Methylation
    • Guangzhou, Guangdong, China
      Sun Yat-sen university cancer center
    Nov 20, 2023

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Cancer of Unknown Primary Site Trial in Houston (Sintilimab)

    Recruiting
    • Cancer of Unknown Primary Site
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Head Neck Cancer, Unknown Primary Cancer, Head and Neck Squamous Cell Carcinoma Trial in Dallas (Pegsitacianine)

    Not yet recruiting
    • Head and Neck Cancer
    • +2 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Jan 18, 2023

    Carcinoma of Unknown Primary: A Comparison Across Tissue and

    Recruiting
    • Cancer of Unknown Primary Site
      • Bath, United Kingdom
      • +6 more
      Oct 18, 2022

      Cancer of Unknown Primary, Bone Cancer Metastatic, Tislelizumab Trial in Shanghai (Tislelizumab plus chemo)

      Recruiting
      • Cancer of Unknown Primary
      • +5 more
      • Tislelizumab plus chemotherapy
      • Shanghai, Shanghai, China
        ChangZheng Hospital
      Feb 6, 2022

      Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

      Recruiting
      • Neuroendocrine Tumors
      • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 19, 2023

      Cancer of Unknown Primary Site Trial in Shanghai (tissue-of-origin (ORIGIN-PanCA?R) profiling)

      Completed
      • Cancer of Unknown Primary Site
      • tissue-of-origin (ORIGIN-PanCA○R) profiling
      • Shanghai, China
        Fudan University Cancer Hospital
      Jan 21, 2022

      Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

      Recruiting
      • Adenoid Cystic Skin Carcinoma
      • +38 more
      • Biopsy
      • +6 more
      • Los Angeles, California
      • +35 more
      Jan 31, 2023

      Carcinoma of Unknown Primary Trial in Calgary, Edmonton, Ottawa (Pembrolizumab Injection)

      Recruiting
      • Carcinoma of Unknown Primary
      • Pembrolizumab Injection
      • Calgary, Alberta, Canada
      • +2 more
      Feb 18, 2022

      Cancer of Unknown Primary Site Trial in Bendigo, Melbourne, Warrnambool (68Ga-FAPi-46, PET/CT imaging)

      Not yet recruiting
      • Cancer of Unknown Primary Site
      • Bendigo, Victoria, Australia
      • +2 more
      Feb 28, 2022

      Heart Failure, COPD, Diabetes Trial in Milan (Outpatient visit)

      Recruiting
      • Heart Failure
      • +7 more
      • Outpatient visit
      • Milan, Italy
        San Raffaele Hospital
      Feb 3, 2023

      Tumor, Ovarian, Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer Trial (AVB-001 (Dose Escalation Phase), AVB-001 (Dose

      Not yet recruiting
      • Neoplasm, Ovarian
      • +7 more
      • AVB-001 (Dose Escalation Phase)
      • AVB-001 (Dose Expansion Phase)
      • (no location specified)
      Sep 15, 2022

      Circulating Biomarkers in Oropharyngeal Cancers

      Active, not recruiting
      • Oropharynx Squamous Cell Carcinoma
      • +3 more
        • Orebro, Sweden
          Anna Oldaeus Almerén
        Jun 13, 2023

        Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,

        Not yet recruiting
        • Fallopian Tube Carcinosarcoma
        • +14 more
        • Biopsy
        • +6 more
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Jun 28, 2023

        Cancer of Unknown Primary Trial in Shanghai (Recombinant humanized anti-PD-1 mAb injection)

        Recruiting
        • Cancer of Unknown Primary
        • Recombinant humanized anti-PD-1 monoclonal antibody injection
        • Shanghai, China
          Fudan University Shanghai Cancer Center
        Apr 18, 2022

        Analgesia, Surgery, Cancer of Head and Neck Trial in Copenhagen (Dexamethasone, Placebo)

        Active, not recruiting
        • Analgesia
        • +6 more
        • Copenhagen, Denmark
          Department of Otorhinolaryngology, Head and Neck Surgery & Audio
        Oct 14, 2022

        Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

        Recruiting
        • Adenocarcinoma
        • +8 more
        • Radiotherapy targeted to the primary lesion
        • +7 more
        • Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 7, 2023

        Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in

        Completed
        • Acinar Cell Adenocarcinoma of the Pancreas
        • +39 more
        • Chicago, Illinois
        • +1 more
        May 7, 2020